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Abstracts / Osteoarthritis and Cartilage 22 (2014) S1–S6 S3pain and improve joint function in patients with end-stage post-trau-
matic OA. This result, combined with the observation that chon-
droprogenitor cells are active in osteoarthritic joints, suggests that
altered loading creates an environment that promotes beneﬁcial joint
remodeling.
Conclusions: Taken together, these recent advances in understanding
of how mechanical forces cause loss of articular cartilage, including
identiﬁcation of mechanically induced mediators of cartilage loss, and
of how changing joint loading can promote joint remodeling provide
the basis for new biologic andmechanical approaches to the prevention
and treatment of all forms of OA.
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RESEARCH TOOLS FOR THE STUDY OF ASPECTS OF THE EPIGENETICS
OF OSTEOARTHRITIS
I.M. Clark. Univ. of East Anglia, Norwich, United Kingdom
Osteoarthritis (OA) is a degenerative joint disease characterised by
degradation of articular cartilage as well as thickening of the sub-
chondral bone and the formation of osteophytes at the joint margin. The
aetiology of OA is complex with genetic, developmental, biochemical
and biomechanical factors contributing to the disease process. Aberrant
gene expression has clearly been shown in OA and epigenetic mecha-
nisms may contribute to this. Epigenetic modiﬁcations may include:
DNA methylation, histone modiﬁcations and non-coding RNA expres-
sion (both microRNA and long non-coding RNA). A number of studies
have compared epigenetic modiﬁcations in OA and normal tissues and
examined epigenetic mechanisms which impact upon the disease. Key
to dissecting the function of epigenetics in OA is the methodology by
which these changes can be measured. This workshop will explore
aspects of the research tools which can be used for the study of epi-
genetics in OA. It will discuss tools which are appropriate in either the
culture ﬂask, or in limiting tissue samples. The scale of the study is also
important since measuring genome wide changes requires different
approaches from determining a single epigenetic mark. Quantiﬁcation
may also be key where different technologies show degrees of accuracy
or linearity which may alter conclusions or require further validation.
The workshop is not a lecture on epigenetics and OA, but rather a dis-
cussion of the tools available for researchers to apply in this area and
their strengths and weaknesses.
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USING ZEBRAFISH TO PROBE THE GENETICS OF OSTEOARTHRITIS
L.H. Brunt y, J. Norton y, S. Reynolds y, E. Moro z, A. Hayes x, E. Rayﬁeld y,
C.L. Hammond y. yUniv. of Bristol, Bristol, United Kingdom; zUniv. of
Padova, Padova, Italy; xUniv. of Cardiff, Cardiff, United Kingdom
Purpose: The purpose of our work is to ascertain the extent to which
zebraﬁsh can be used as an animal model to dissect how osteoarthritis
susceptibility genes affect cell behaviour in the formation and main-
tenance of joints.
Methods: Using BAC recombineering we have generated a number of
transgenic lines in which ﬂuorescent reporters are expressed under the
control of promoters linked to cartilage biology, for example Type 2 and
Type X Collagens and Gdf5, as well as reporters for the activity of a
number of signalling pathways including Wnt and Hedgehog; allowing
us to visualise cell behaviour in real time in the translucent ﬁsh. We
have used a number of histological and immunohistochemical methods
along with electron microscopy and microCT to characterise a number
of events in zebraﬁsh cartilage development, joint formation and during
skeletal ageing. We have also generated Finite Element models that
allow us to visualise the biomechanical strains experienced in zebraﬁsh
jaw elements resulting from the action of their associated muscles.
Results: Using a combination of techniques we show that in the
zebraﬁsh normal joint morphogenesis requires muscle action, and
occurs through changes to cell organisation and orientation. We show
using Finite Element Analysis that positions of high biomechanical
strain in the zebraﬁsh joint overlap regions of high Wnt signalling
activity, and show that Wnt signalling is required downstream of
muscle activity for correct joint morphogenesis. We also show that
cartilage in ageing ﬁsh show a number structural and biochemical
changes some of which are reminiscent of those seen in osteoarthritis in
other animal models and in human cartilageConclusions: Taken together we conclude that zebraﬁsh can be a useful
animal model to dissect the role of osteoarthritis susceptibility genes in
the behaviour of chondrocytes during joint development, homeostasis
and ageing in normal and pathological situations.
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PROTEOMICS AND BIOMARKERS IN OSTEOARTHRITIS
A.O. Aliprantis, S. Ritter. Brigham and Women’s Hosp., Boston, MA, United
States
Purpose: The application of modern proteomic techniques to disease
states affords the opportunity to identify deregulated pathways that
contribute to pathogenesis. These discoveries in turn may lead to new
therapeutic targets, as well as “wet” biomarkers that aid in diagnosis,
prognosis and the prediction of treatment responses. Building on the
concept that osteoarthritis (OA) is a disease of all joint structures
(synovium, cartilage and bone), and that synovial ﬂuid (SF) may rep-
resent of synthesis of inputs from these structures, we compared the
proteomic proﬁle of knee joint SF from patients with early and late stage
OA to unaffected controls by 2-dimensional gel electrophoresis and
mass spectrometry. In our recent publication, using this relatively
unbiased approach, 66 proteins were reported as differentially repre-
sented in healthy vs. OA SF (1). Pathway analysis identiﬁed three bio-
logic processes among these proteins: the complement and coagulation
systems and the acute phase response. Interestingly, early and late OA
manifested a very similar proteomic proﬁle. Together, these ﬁndings
suggest the osteoarthritic disease processes involves activation of
inﬂammatory pathways that are well-established by the time patients
are diagnosed. This presentation will explore 1) the relative con-
tribution of joint tissues to the SF OA proteome, including cartilage and
synovium, 2) how proteomics can illuminate the pathogenesis of OA to
identify therapeutic targets, 3) validation of proteomic discovery ﬁnd-
ings using multiplexed selected reaction monitoring (SRM) mass
spectrometry peptide assays and 4) translation of SF protein biomarkers
to quantitative serum based assays to predict disease progression in OA
patients. At the end of this presentation, attendees should understand
some of the major protein constituents of OA SF and how knowledge of
this proteome may inform pathogenesis and biomarker development
for this difﬁcult disease.
1. Ritter SY, Subbaiah R, Bebek G, Crish J, Scanzello CR, Krastins B,
Sarracino D, Lopez MF, Crow MK, Aigner T, Goldring MB,
Goldring SR, Lee DM, Gobezie R, and Aliprantis AO. Proteomic
analysis of synovial ﬂuid from the osteoarthritic knee: com-
parison with transcriptome analyses of joint tissues. Arthritis
Rheum 2013;65:981–992.
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HOW LIFESTYLE FACTORS INFLUENCE THE DEVELOPMENT AND
PROGRESSION OF OA
D. Dunlop. Northwestern Univ., Chicago, IL, United States
Purpose: Osteoarthritis (OA) is the most commonworldwide disease of
joints and its prevalence is growing. The worldwide obesity epidemic in
older adults is fueling an increase in many chronic diseases, including
osteoarthritis. This presentation will focus on knee OA, which is the
most prevalent form of OA and a major cause of arthritis-related
functional loss and disability.
The American College of Rheumatology 2012 recommendations rec-
ognize lifestyle factors, including weight loss and physical activity, as
primary nonpharmacologic therapies for OA. Obesity has long been a
recognized risk factor for the development of knee OA. Obesity con-
tributes to OA through joint load, altered gait, and impaired muscle
performance. Importantly weight inﬂuences the course of disease
progression. Longitudinal cohort data provide evidence for a dose
response relationship between weight change and function. Notably,
45% of adults with a weight loss 10% had a clinically meaningful
improvement in WOMAC function. Randomized controlled clinical tri-
als (RCT) support the effectiveness of weight loss to improve function in
adults with knee OA. RCT evidence in obese knee OA patients demon-
strated a 10% weight loss% could improve self-reported function by
more than 25%.
Abstracts / Osteoarthritis and Cartilage 22 (2014) S1–S6S4Physical activity is a more recent addition to non-pharmaceutical
interventions. In 2008, the US published federal guidelines recom-
mending adults with arthritis participate in 150 minutes of moderate
activity each week accumulated in sessions lasting at least 10 minutes.
Physical activity beneﬁts are supported by dose-response relationships
with better physical function based on longitudinal cohort studies. RCTs
demonstrate the effectiveness of both exercise interventions and
resistance training to improve function and reduce disability in adults
with knee OA. Recent RCTs provide insight into the synergy between
weight loss and physical activity in knee OA. Exercise alone and weight
loss alonewere each effective to improve function; however weight loss
plus exercise had the greatest effect.
These studies support interventions which increase moderate intensity
activity. However, many adults are not candidates to engage in mod-
erate intensity activities due to health limitations. What strategies are
available to these adults? Recent work demonstrated sedentary
behavior is a signiﬁcant risk factor for functional loss in adults including
those with knee OA. Importantly, this relationship is independent of
obesity status and of time spent in moderate intensity activities. These
ﬁndings support replacing sedentary timewith light activity to improve
health outcomes in adults with knee OA who cannot perform/increase
moderate intensity activities.
Taken as a whole, life style interventions provide important strategies
to prevent knee OA and mitigate its consequences. Weight control can
reduce the risk of developing knee OA. For overweight adults with
knee OA, weight loss can effectively improve function. Engaging in
physical activity of moderate intensity can improve function and
reduce disability. Weight loss combined with increased activity pro-
vides added beneﬁts for overweight adults. While the beneﬁts of
physical activity are substantial, not all older adults are candidates to
engage in moderate intensity activities. An alternative strategy is to
replace time spent in sedentary behavior with light intensity activities
to improve function.
I-10
BE IT RESOLVED: PLAIN RADIOGRAPHY OR MRI – WHICH IS BETTER
IN ASSESSING OUTCOME IN CLINICAL TRIALS?
F. Eckstein y, M.-P. Hellio Le Graverand z. y Paracelsus Med. Univ.,
Salzburg, Austria; z Pﬁzer Dev. Japan, Tokyo, Japan
Purpose: Imaging in clinical trials is commonly used to evaluate the
efﬁcacy of a therapeutic intervention, but also for subject eligibility and
safety. The results of clinical trials can support decision making in
DMOAD development, by ascertaining treatment effects on joint
structure, potentially before these translate to clinical beneﬁts. This
debate will focus on the use of radiography and magnetic resonance
imaging (MRI) in research trials and in clinical trials of knee osteo-
arthritis. Depending on the context, the strength and weaknesses of
each imaging technique will be highlighted and performance will be
compared.
Methods: The authors have performed a full-text literature on imaging
of the knee, with a focus on bone and cartilage, adding primary expe-
rience in the implementation of imaging methods in clinical trials, and
results presented at recent conferences.
Results: The authors will present summary data on the reliability
(consistency, test-retest precision) of radiographic measurement of
joint space width (JSW) and cartilage thickness with MRI. They will
address the construct, concurrent and predictive validity of both
methods, compare their sensitivity to change in knee OA in studies that
examined JSW and cartilage thickness change in the same subjects, and
highlight the speciﬁc potential and the limitations of each imaging
technique. Finally, the correlation with clinical outcomes and the
response to treatment will be addressed.
Conclusion: Current imaging methodologies provide powerful tools for
evaluating morphological and compositional aspects of most articular
tissues, capturing longitudinal change with reasonable to excellent
sensitivity. Radiography and MRI are complementary imaging techni-
ques; each has speciﬁc strengths and weaknesses that depend on the
speciﬁc context of the questions asked. When employed properly, each
of them involves potential for ascertaining treatment effects on joint
structure, potentially over shorter time scales than required for dem-
onstrating effects on clinical outcomes.I-11
NON-CARTILAGE CHANGES VISUALIZED BY MRI AND RISK FOR OA
DEVELOPMENT/PROGRESSION
M.D. Crema. Boston Univ., Boston, MA, United States
Non-cartilaginous tissues that may be affected in osteoarthritis (OA)
include the subchondral bone, synovium, ﬁbrocartilage, ligaments and
muscles. Due to its capability to visualize pathology in different tissues
with excellent contrast, magnetic resonance imaging (MRI) provides
high-resolution andmultiplanar assessment of the bone and soft tissues
mentioned above. The use of semiquantitative and quantitative MRI
biomarkers of non-cartilaginous tissues in clinical and epidemiological
OA studies is reviewed. Bone marrow lesions (BMLs) are deﬁned onMRI
as non-cystic subchondral areas of ill-deﬁned hyperintensity on ﬂuid-
sensitive spin-echo sequences, and were shown to be associated with
incidence and progression of knee OA, including progression of MRI-
detected cartilage loss and radiographically detected joint space nar-
rowing (JSN). MRI is the best imaging method for the detection and
grading of BMLs. The close relationship between BMLs and cartilage
damage in the same region of the joint was extensively demonstrated in
previous studies. BMLs represent a highly variable feature in patients
with or at risk for development of knee OA, as their size may increase or
decrease over time. This is of relevance since it was demonstrated that
the ﬂuctuation of BML size over time seems to have a direct effect on
progression of disease assessed on a subregional basis. MRI is also
capable to accurately assess the morphology of the subchondral bone,
especially in the detection of any degree of subchondral ﬂattening or
depression, also known as subchondral bone attrition. A strong asso-
ciation exists between subchondral bone attrition and subchondral
BMLs in the same region of the knee, and the association increases with
BML size. Further, it was demonstrated that attrition represents a risk
factor for progression of cartilage loss in the same compartment of the
knee. Meniscal damage including tears and maceration, as well as
meniscal extrusion, were shown to be independently associated with
incidence and progression of OA, including progression of radio-
graphically-detected JSN and MRI-detected cartilage loss. MRI is the
method of choice in the assessment of meniscal damage and meniscal
extrusion, with multiplanar spin-echo techniques being the most
appropriate for their detection and grading. Although synovitis in OA is
thought to be a secondary phenomenon related to cartilage deterio-
ration, its importance in the OA process is well recognized. Several
methods for detecting and quantifying synovitis with non-enhanced
and contrast-enhanced MRI are available. Synovitis should be ideally
assessed and quantiﬁed using gadolinium-enhanced MRI, although
surrogate markers for synovitis on non-enhanced MRI are available and
are widely utilized in published studies. There is little evidence that
synovitis is not only a secondary phenomenon in patients with knee OA
but may also play a role in progression of disease. This relationship
remains to be demonstrated in large longitudinal studies. Alternatively,
synovitis can be evaluated in combination with effusion on ﬂuid-sen-
sitive sequences but differentiation between inﬂamed synovium and
joint ﬂuid ﬁlling the joint cavity surrounded by synovium may be dif-
ﬁcult. Ligament injury can be accurately depicted by multiplanar MRI
assessment of joints. In the knee, it was demonstrated that cruciate
ligament deﬁciency secondary to tears increase the risk for incidence or
progression of OA. Further, it was shown that collateral ligaments at
both distal and proximal interphalangeal joints may play a role in early
stages of OA. The role of other non-cartilaginous tissues accurately
assessed by MRI, such as the acetabular labrum (hip) and quadriceps
muscle (knee), and their relationship with structural deterioration in
these joints was also demonstrated in a few studies. This presentation
reviews the role of non-cartilage structures, as well as pathology in
these structures, in the development and/or progression of OA, focusing
in the knee joint, based on the evidence in the literature.
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GENETICS/GENOMICS IN OSTEOARTHRITIS
A. Tsezou. Univ. of Thessaly, Faculty of Med., Larissa, Greece
In this year review recent developments in genetics/genomics of
osteoarthritis (OA) are discussed to improve our understanding of OA
pathophysiology. In OA genetics, a meta-analysis of genome wide
association studies (GWAS) revealed novel loci for hip OA, among which
